Upon a full week's reflecion of events from the trial, I'm going to make a post tomorrow about how TPL and it's associated enterprise, Alliacense, have so severely wounded the potential revenue generation and reputation of the MMP licensing program, and inturn the value of our individual investments in PTSC, that TPL and Alliacense need to be distanced, marginalized and removed from any licensing control, authority, decisionmaking or representation well before this year ends.

I think this may very well should be PTSC leadership's and we as shareholders #1 strategic goal to increase our revenues and regain control of our assets and our own financial destiny. Think about such an event, and how much more successful your investment would be without TPL's continued public association with the MMP licensing program, and damaging influence on our shareholder communications, transparency, and stock price.

I also think it's in PTSC's leadership's own best interest to support the above, because I think the fallout and transactional publicity from the HTC trial contains important messages for them too.